Please try another search
Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China. The company’s products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro and lispro mix 75/25 injection; Prandilin 25, an insulin lispro injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection. It also offers GanleePen, an insulin injection device; GanleeFine, an insulin pen needle; and medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Gan Zhongru | 74 | 1994 | Founder & Chairman |
Tao Zhang | 45 | 2021 | Chairman of the Board of Supervisors |
Wei Chen | 43 | 2021 | Director |
Lei Yin | 44 | 2021 | Director |
Weiqiang Song | 41 | 2015 | Deputy GM & Director |
Kai Du | 46 | 2019 | GM & Director |
Jiaxin Wang | 30 | 2019 | Supervisor |
Yi Wang | 33 | 2021 | Supervisor |
Zengyi Chang | 58 | 2022 | Independent Director |
Yanqing He | 38 | 2019 | Independent Director |
Guojun Zheng | 55 | 2019 | Independent Director |
Jiao Jiao | 35 | 2021 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review